Heerlen, NL, 09 Dec 2016 09:00 CET
Royal DSM, a global science-based company active in health, nutrition and materials, has repurchased 361,907 of its own shares in the period from 2 December 2016 up to and including 8 December 2016 at an average price of €56.21. This is in accordance with the repurchase, covering existing option plans, announced on 4 November 2016. The consideration of this repurchase was €20.3 million.
This repurchase concludes the program to repurchase 1,700,000 shares for a total consideration of €96.0 million.